1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics 2022 - Italy

Chronic Disease Analysis & Statistics 2022 - Italy

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • GlobalData

All regions

  • All
    • Europe
      • Italy
1-8 of 8 reports

Systemic Sclerosis (Scleroderma) - Epidemiology Forecast to 2030

  • $ 3995
  • May 2021
  • 42 pages

Systemic Sclerosis (Scleroderma) - Epidemiology Forecast to 2030 Summary Systemic sclerosis (SSc) is an autoimmune disorder of small arteries, microvessels, and connective tissue.SSc is characterized ...

  • United States
  • Italy
  • Musculoskeletal Disorder
  • Epidemiology
  • Industry analysis
  • Prescription Drug Sales
  • Health Provider Density

Chronic Obstructive Pulmonary Disease: Epidemiology Forecast to 2028

  • $ 3995
  • December 2019
  • 38 pages

Chronic Obstructive Pulmonary Disease: Epidemiology Forecast to 2028 Summary Chronic Obstructive Pulmonary Disease (COPD) is a progressive disease characterized by coughing that produces large amounts ...

  • Germany
  • Italy
  • Respiratory Disease
  • Epidemiology
  • Industry analysis
  • Chronic Obstructive Pulmonary Disease Prevalence
  • Smoking Prevalence

Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2029

  • $ 10995
  • October 2020
  • 199 pages

Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2029 Summary Type 2 Diabetes Mellitus, or T2D for short, refers to a defect in insulin secretion and sensitivity, whereby the ?-cells in ...

  • United States
  • China
  • Type 2 Diabetes
  • Industry analysis
  • Diabetes Prevalence
  • Overweight Prevalence

Osteoporosis: Epidemiology Forecast to 2027

  • $ 3995
  • April 2018
  • 41 pages

Osteoporosis: Epidemiology Forecast to 2027 Summary Osteoporosis is a disease in which the density and quality of bone are reduced over time.In a normal process known as remodeling, some of a person’s ...

  • Japan
  • Spain
  • Musculoskeletal Disorder
  • Industry analysis
  • Health Expenditure
  • Cancer Mortality

EpiCast Report: Macular Edema - Epidemiology Forecast to 2026

  • $ 3995
  • November 2017
  • 42 pages

EpiCast Report: Macular Edema - Epidemiology Forecast to 2026 Summary Macular edema (ME) is a condition characterized by the thickening and swelling (edema) of the macula, which is the area of the retina ...

  • United States
  • Spain
  • Type 2 Diabetes
  • Industry analysis
  • Diabetes Prevalence
  • Hospital Occupancy Rate

EpiCast Report: Pulmonary Arterial Hypertension - Epidemiology Forecast to 2026

  • $ 3995
  • October 2017
  • 50 pages

EpiCast Report: Pulmonary Arterial Hypertension - Epidemiology Forecast to 2026 Summary Pulmonary arterial hypertension (PAH) is a rare and severe condition characterized by vascular proliferation and ...

  • United States
  • France
  • Hypertension
  • Industry analysis
  • Mortality Rate
  • Diabetes Prevalence

PharmaPoint: Macular Edema - Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • November 2017
  • 258 pages

PharmaPoint: Macular Edema - Global Drug Forecast and Market Analysis to 2026 Summary Macular edema (ME) is a condition where fluid and protein deposits accumulate on the macula, causing it to swell, ...

  • United States
  • Japan
  • Therapy
  • Type 2 Diabetes
  • Industry analysis
  • Diabetes Prevalence
  • Drug Approval

EpiCast Report: Systemic Lupus Erythematosus (SLE) - Epidemiology Forecast to 2025

  • $ 3995
  • January 2017
  • 66 pages

EpiCast Report: Systemic Lupus Erythematosus (SLE) - Epidemiology Forecast to 2025 Summary Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of the connective tissue. It can affect any ...

  • United States
  • United Kingdom
  • Musculoskeletal Disorder
  • Epidemiology
  • Industry analysis
  • Morbidity Rate
  • Cancer Mortality



Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on